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Abstract
Background Withholding information from cancer patients is
a common practice in many Asian countries, including China,
Japan, and Singapore, as well as in some Western countries,
such as Spain, Greece, and Italy. Much research has investi-
gated why doctors withhold information from cancer patients
generally, both in the West and the East, but little research has
been done on specifically why Chinese doctors withhold such
information.
Methods Three focus group interviews were conducted with a
total of 16 oncologists in China. The interviews were record-
ed, transcribed, and translated. Qualitative data were analyzed
using systematic text condensation.
Results The result of this study revealed numerous circum-
stances that can lead to non-disclosure of cancer-related infor-
mation. Many of these circumstances have been described in
previous studies about non-disclosure in other countries. We
found two additional circumstances that have not been de-
scribed in previous literature and might therefore expand our
current knowledge about this phenomenon; they are contra-
diction between laws and fear for personal safety.
Conclusion Numerous circumstances can lead to non-
disclosure of cancer-related information. This study found
two additional circumstances that might lead to non-
disclosure. The findings of this study suggest further
assessment and clarification about the laws that govern
doctor-patient communication and that action should be
taken to ensure safe working environments for Chinese
oncologists.
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Introduction
Non-disclosure of cancer-related information is here de-
fined as the act of withholding information about cancer
diagnosis or prognosis. Withholding information about
cancer diagnosis or prognosis is a common practice in
many Asian countries, including China, Japan, and
Singapore [1–4], but also in some Western countries, such
as Spain, Greece, and Italy [5–7].
Previous research suggests that doctor’s attitude toward
cancer diagnosis disclosure is influenced by the way they
try to find a balance between the two medical ethical
principles respect for patient’s autonomy and non-
maleficence. Some countries affirm the importance of
truth telling based on the principle of autonomy; while
in other countries, the principle of non-maleficence is su-
perior to autonomy. Previous studies suggest that
Japanese doctors would consider the negative conse-
quences of disclosing a cancer diagnosis and act accord-
ingly, even if they have to sacrifice autonomy [3].
Many factors can lead to non-disclosure of cancer-
related information. They include, but are not limited
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to, fear of causing psychological morbidity to the pa-
tient, patients reluctance to be informed, physician’s
self-interest to conceal the truth, language barrier, lack
of time and an appropriate place, psychological distress
for the doctor, negative impact on emotional well-
being and work satisfaction, family’s request of Bdo
not tell,^ and lack of training, guidelines, and research
[8–11].
A previous study using questionnaires that assessed
Chinese oncologists’ attitude toward truth telling found that
87.5 % of the oncologists believed that patients with early
stage cancer should be informed of the diagnosis, while only
40.5 % believed that patients with late stage cancer should
know the truth [12]. Another study found different attitudes
between Chinese cancer patients and their families. Patients
were more likely to favor disclosure of cancer diagnosis than
their families, both in the early stage 90.8 vs. 69.9 %, and in
terminal stage 60.5 vs. 34.4 % [13]. As far as we know, no
published studies in English have explored circumstances that
might lead to non-disclosure of cancer-related information
among Chinese oncologists.
Despite a global trend toward more disclosure of both
cancer diagnosis and prognosis, the discussion on whether
patients need to know they are terminally ill is ongoing
[14, 15]. In the USA, where some critics claim that auton-
omy is overemphasized, terminal patients might still not
always receive complete information about their prognosis
[16]. Additionally, a study from Norway found that 20 %
of cancer patients were unaware that they had a cancer
diagnosis [17].
A qualitative approach is useful for exploring partici-
pants’ experiences, attitudes, thoughts, expectations, mo-
tives, and interactions [18]. Consequently, and since there
is a lack of knowledge about the topic in question, we
decided to perform a qualitative study. Further, we have
chosen to conduct focus group interviews, as they are
suited to produce data about a group’s interpretation, in-
teraction, and norms [19].
The authors of this article are from Norway, which
practices full-disclosure of cancer-related information.
We were aware that this was different in China and
wanted to explore possible reasons and circumstances
for this difference. The first author is a Chinese born
Norwegian citizen who immigrated to Norway at an early
age and has training in Western medicine. The second
author is trained in, and has conducted research in, tradi-
tional Chinese medicine. On his many visits to Chinese
hospitals and cancer departments, the issue around non-
disclosure of cancer-related information to patients has
been present. Hence, we wanted to perform this study to
explore and describe circumstances and the rationale a
selected group of Chinese oncologists gave for disclosing
or withholding cancer diagnosis to their patients.
Design, material, and methods
We chose a focus group design because it allows sharing of
experiences, interaction, and communication between the par-
ticipants on the difficult questions that were the focus of our
study. To allow for differences, we invited oncologists, from
three different hospitals in Beijing, China, to participate.
Hence, we arranged for three focus group interviews, with
participants in each group knowing each other well from their
shared clinical work. Because of time-related issues and lack
of funding, we ended up with a combination of purposive and
convenience sample. The first author scheduled appointments
through a gate keeper with oncologists from three oncology
wards and visited the oncology wards to present the study to
the oncologists. Those who were interested were asked to
write down their names and title. We included all the partici-
pants that were interested in participation. Our sample consists
of 16 doctors working in oncology wards, 12 females and 4
male doctors who were aged 26 to 48. Years of work experi-
ence related to cancer patients ranged from 1 to 23, with an
average of 10.3 years. There were five participants in each of
the two focus groups and six participants in the third focus
group. The study was approved by the Regional Committee
for Medical and Health Related Research Ethics in Norway.
All three interviews were audio-recorded with the first au-
thor as moderator (fluent in Chinese). Interviews took place in
different hospital rooms, each lasting for about 1 1/2 h. The
moderator used an interview guide with pre-specified ques-
tions that was tested and modified after a pilot focus group
interview with Chinese medical students. The interview guide
was based on a funnel approach, with general and open-ended
questions in the beginning for free discussion to more specific
questions towards the end [19]. All participants were prom-
ised anonymity in the published article; hence, quotations
used in this text are anonymous. The transcripts were tran-
scribed and then translated into English by a certified medical
and legal court interpreter. Both authors cooperated on the
analysis. This was accomplished by systematic text conden-
sation [20–22]: (1) reading all the material to obtain an overall
impression and bracketing previous preconceptions, (2) iden-
tifying units of meaning, representing different aspects of the
doctor’s experiences with withholding medical information,
(3) condensing the contents of each of the coded groups, and
(4) summarizing the contents of each code group to describe
circumstances that might lead to non-disclosure of cancer-
related information in a hospital setting.
Results
Our analysis revealed numerous circumstances that could lead
to non-disclosure of cancer-related information. These in-
clude, but are not limited to fear of causing psychological
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morbidity, family’s request of Bdo not tell,^ lack of training,
time, and environment. However, two of our findings have not
been described in previous literature. They are fear for per-
sonal safety and contradiction between laws, and they are
therefore further described in the following.
Fear for personal safety
Most of the oncologists agreed that the most common reason
they would hold back information related to cancer diagnosis
or prognosis is by request from the patient’s family. The pa-
tient’s family plays an important role both during and after the
patient’s visit to the hospital and is almost always present and
participates in the consultation with the oncologists. The di-
agnosis would usually be disclosed to the family first without
the patient present. All of our participants agreed that it is
important to cooperate with the patient’s family, and this
might be different from overseas. One senior oncologist ex-
plained that BI think in China seeing a doctor is like [seeing] a
network of families. You are completely wrapped in it. Maybe
families very rarely have such big impact on a patient’s treat-
ment in foreign countries as they do in China. No matter it is
the emotional support, or the financial support. It is such a
gigantic system, that it is very hard to be separated. It indeed
plays a very big role during the treatment.^
Most of our participants further agreed that following the
family’s request is an unwritten rule. They further explained
that they would object to withholding information about a
cancer diagnosis if they felt that it is not in the patient’s best
interest. One oncologist expressed a different attitude, believ-
ing that it is not a decision that the patient’s family has the
right to make. Even if the family insists he would still tell the
patient if asked directly by the patient.
One oncologist described her routines in the outpatient
clinic: Bfor instance if I have this question in outpatient clinic,
the patient asks what do I have, I will first look at the patient’s
family member. Look at the person behind him first. If this
person gives me a signal in his glance, then I know he does not
know. Then I will tell him right away there is no big problem,
it is probably a small cyst or something, and purposefully
withhold the conditions from him. Because if I tell him right
there, the family will probably throw his fist at me. So I must
first protect myself. Then after the patient gets out, I will talk
to the family. Maybe I will tell the family that you should let
him know, even if you cannot tell him right away, you should
tell him gradually.^
All of the groups believed that by not following the norm of
consulting the family before disclosing cancer-related infor-
mation might result in malpractice suits, being blamed for the
deterioration of the patient’s condition after disclosure, dis-
putes with the family, risk of verbal assault, and even the risk
of physical violence. Most of our participants believe that the
patient’s family would know the patient better, and that it is
wise to consult the family before disclosing any cancer-related
information in order to assess how the patient might react.
Several participants explained that early communication with
the family and letting the family understand the doctor’s ac-
tions might reduce the risk of potential misunderstandings.
A senior oncologist explained: Bwhat is weighted the most
nowadays is probably the family’s opinion… the family force
is the most important force in the society, we need to consider
the family’s opinion. If we do not consider the family’s opin-
ion, the consequences can be very serious; we may be beaten
or scolded, or involved in law suits in many cases. So no
matter from a cultural perspective, or from a practical point
of view, we need to respect the family’s opinion. So this is the
first thing laid in front of us. The second is about the patient’s
strength. Who knows about his strength? The family knows,
but the doctor doesn’t know. Because in the beginning when
[the patient] is sick,… we recommend [the family] to tell [the
patient], which is, to protect [the patient’s] right to informed
consent. But in the end, we need to [know] how [the patient’s]
emotional strength is, how [the patient] handles things, then
we let the family exercise their discretion. [We will] ask the
family’s advice whether I may tell [the patient] or not. If the
family says no, don’t tell [the patient], then we cannot insist on
telling the patient, which will for sure lead to disputes.^
Contradiction between laws
A central theme that all of the groups brought up without
prompting the issue is the contradiction of the laws concerning
patient’s rights to information in China. One law states that
patients have the right to know about their condition. A sec-
ond law states that it is inappropriate for the healthcare pro-
viders to inform the patient if it would cause adverse events. A
third law grant doctors the right to withhold information with
good intent. In such case, the doctor should inform the pa-
tient’s family in order to avert adverse consequences.
One oncologist explained: BThe 62nd section of the
Specifics in Regulation of Management of Medical
Institutions also points out that Bif it is inappropriate for the
healthcare providers to inform the patient during protective
medical procedures, they should inform the patient’s family
of the relevant conditions^… The same oncologist further
explained: Bthe healthcare providers have a special right to
intervene,… which includes the healthcare providers’ right
to withhold information with good intentions. This is granted
by the nation, the patient has the right to learn the diagnosis
and prognosis of [his/her] disease, the doctor should tell the
patient the truth, but if the diagnosis or prognosis is serious, it
may affect the treatment or even cause serious consequences
once the patient knows about it. At this time the doctor should
use his right to intervene, not to inform or to temporarily
withhold information, but they should tell the patient’s family
the truth.^
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Another oncologist summarized the issue: BFirst, the law
grants patients the right to informed consent. [The patient]
should know. Secondly, we need to avoid adverse conse-
quences. Thirdly, we as doctors have the, the right to inter-
vene. The three types of rights put together, generate an am-
biguous, oh, a random thing. Then how do you decide to
inform or not to inform…^
Several oncologists added that this contradiction is solved
differently at different hospitals. Some hospitals have
surrogation agreement which relieves doctors from their ob-
ligations to inform the patient.
One oncologist explained: B…it seems almost every
patient needs to sign a surrogation agreement,… upon
admission, in particular for in-patients, we have this for
almost every patient, which states that I entrust [the pa-
tient’s family] with my affairs. With this statement, we
doctors are protected by law. We can talk to the surrogate
about his conditions; we are no longer obligated to inform
the patient himself…^
A senior oncologist expresses discontent with the cur-
rent situation in his/her hospital: BThere is one line in our
informed consent [form], which says that the doctor has
the right to inform the patient, assuming that it does not
cause any harm to the patient’s health and interest. How
do I know under what circumstances a patient’s interest
will be harmed?^
Discussion
The aim of this study was to explore circumstances that
might lead to non-disclosure of cancer-related informa-
tion. Non-disclosure of cancer-related information is in
this article referred to the conscious act of withholding
information regarding cancer diagnosis or prognosis.
Withholding cancer-related information is common in
many Asian and some Western countries. Our findings
suggest that the practice of non-disclosure of cancer-
related information in China is assessed individually for
each patient. Our findings further suggest that this prac-
tice is similar to those in cultures centered on family
values [23]. The role and importance of the patient’s fam-
ily, as suggested by our participants, are crucial in the
understanding of why Chinese doctors withhold the can-
cer diagnosis. Contradictions between laws make it diffi-
cult for doctors to disclose information even when they
believe it to be right.
But where previous literature suggests family and the
doctor jointly agree to assume a protective role by not
disclosing the diagnosis, our findings suggests the deci-
sion is not solely based on the doctors’ discretion. While
the doctors can try to persuade the family from withhold-
ing the diagnosis, the final decision seems to lie within
the patient’s family. This shift of power might be caused
by the contradictions within Chinese laws, and perhaps
also by doctors’ fear for personal safety. Numerous re-
ports of violence against doctors in China have been re-
ported in Chinese media and international medical
journals [24].
A qualitative study on cancer disclosure in Japan found
that Japanese doctors can be divided into tellers, defined
as those who would usually but not always disclose, and
non-tellers, defined as those who usually would not tell
but in some circumstances may disclose [3]. Japanese
tellers would also avoid consulting the family first and
reportedly experience very few problems from the family
despite such an approach. The results of our study do not
suggest such a distinction, and none of our participants
described following the approach by Japanese tellers.
Nevertheless, a distinction between those who would resist
the family’s request to withhold and those who would follow
the family’s advice and wishes can be found in our material.
Several of our oncologists described how they would continue
to persuade the family to disclose the diagnosis if they be-
lieved it to be wrong to withhold. One oncologist stated that
he/she would reveal the diagnosis if asked by the patient di-
rectly. These attitudes and approaches were only expressed by
senior doctors. One junior doctor explains that this ap-
proach is easier to pull off because patients’ families have
more respect for senior doctors. BDon’t waste your money
on a young doctor^ is a saying in China. One oncologist
hypothesized that the deterioration of doctor-patient/family
relationship is also partly caused by the commercialization
of health care in China. Some medical treatment is so
expensive that it can cause catastrophic medical expenses
and lead to unrealistic expectations of treatment results.
Since most actions are taken by the patient’s family, such
as law suits, it is important to include and listen to the
family from an early stage.
A recent study [25] suggests change in Japanese leg-
islation may have increased the incidence of a cancer
diagnosis being disclosed. But a review article of court
decisions and characteristics of Japanese culture suggests
that the current Japanese legal norms regarding informed
consent and information disclosure still raise concerns,
and that these concerns might be related to aspects of
Japanese culture [26].
We chose focus group interviews as the method for data
collection. The advantages of using focus group interviews are
that it allows us to collect data about a group’s opinions and
perceptions and observe how the group interacts. It is an ef-
fective method for collecting large amount of data in a short
period of time compared to in-depth interviews. Because
much research has already been conducted in this area, we
wanted to compare and see if our data could expand or chal-
lenge existing knowledge through our participants’
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spontaneous interactions with each other. The disadvantages
of using focus group interviews is that it can be difficult to
encourage everyone in the group to participate, especially if
there is a hierarchy in the group and there are disagreements.
Focus group interviews may also produce a large amount of
information that can be difficult to analyze.
Because this topic has been researched inmany other coun-
tries, data collection and analysis were focused on finding
circumstances that have not been previously described. After
analysis, we emerged with two findings that as far as we know
have not been described in previous research. They are fear for
personal safety and contradiction between laws. Two re-
searchers with different backgrounds, both professionally
and culturally, have been involved in the interpretation of
the data.
This study is limited to a sample of oncologists work-
ing in hospitals in a major city. Different medical special-
ists such as radiologists might approach this question dif-
ferently. The situation might also be different outside a
hospital setting or in other parts in China. The results of
this study are limited to oncologists’ perspective. A study
of nurses’ experience of caring for cancer patients not told
of their diagnosis suggest nurses believe the rights of the
patient should override those of the relatives [27]. This
suggests other health professions might have different at-
titudes towards cancer disclosure practice.
It is beyond the scope of this study to provide a com-
plete overview of circumstances that might lead to non-
disclosure of cancer-related information in China or to
reveal the mechanism in which these clinical decisions
are made. We welcome studies that seek to elucidate these
questions. In-depth interview studies can explore the
views, experiences, beliefs, and motivations of individuals
and can reveal and explore sensitive topics where partic-
ipants may not want to talk about such issues in a group.
More research is needed about the patient’s family’s role
in patient-doctor relationships in China, and whether other
life threatening diagnose, such as end-stage renal failure
or severe heart failure, would also be associated with non-
disclosure. The findings of this study suggest an assess-
ment and clarification about the laws that govern doctor-
patient communication and it would also be interesting to
know if doctors in other countries are affected by similar
laws. Action should be taken to ensure a safe working
environment for Chinese oncologists.
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